FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2987161714> ?p ?o ?g. }

• W2987161714 endingPage "9187" @default.
• W2987161714 startingPage "9177" @default.
• W2987161714 abstract "Accumulating evidence supports the involvement of microRNAs (miRNAs) in the progression of human cancers including glioma. Recently, miR-769-5p has been reported to play a tumor suppressive role in colorectal cancer and lung cancer, whereas it exerts an oncogenic role in melanoma. However, the role of miR-769-5p and its related mechanism are poorly elucidated.The levels of miR-769-5p in glioma tissues and adjacent non-tumor tissues were detected by qRT-PCR. In addition, the effects of miR-769-5p on cell proliferation and apoptosis were evaluated by CCK-8, EdU, colony formation and flow cytometric assays, respectively. Meanwhile, the dual-luciferase reporter assay was used to investigate the interaction of miR-769-5p and lysine methyltransferase 2A (KMT2A) in glioma.We found that miR-769-5p expression was strongly upregulated in glioma tissues and cell lines. Glioma tissues with high World Health Organization (WHO) grades had obvious higher levels of miR-769-5p compared to samples with low WHO grades. Interestingly, glioma patients highly expressing miR-769-5p showed prominent poorer survivals. Knockdown of miR-769-5p significantly suppressed cell proliferation and resulted in apoptosis in glioma cells. Additionally, miR-769-5p silencing restrained in vivo growth of glioma cells in mice. Interestingly, KMT2A was identified to be a direct target of miR-769-5p in glioma cells. The expression of KMT2A mRNA was downregulated in glioma tissues and inversely correlated with miR-769-5p level. KMT2A overexpression inhibited cell proliferation and induced the apoptosis of A172 cells. Moreover, siRNA-mediated KMT2A silencing could partially abolish miR-769-5p knockdown-induced suppressive effects on A172 cells.In summary, our findings suggest that targeting miR-769-5p/KMT2A axis may be a promising therapeutic target for glioma treatment." @default.
• W2987161714 created "2019-11-22" @default.
• W2987161714 creator A5020896315 @default.
• W2987161714 creator A5026786069 @default.
• W2987161714 creator A5028467032 @default.
• W2987161714 creator A5029283228 @default.
• W2987161714 creator A5030212439 @default.
• W2987161714 creator A5041762312 @default.
• W2987161714 creator A5075811929 @default.
• W2987161714 creator A5080256378 @default.
• W2987161714 creator A5086997094 @default.
• W2987161714 creator A5088657051 @default.
• W2987161714 date "2019-11-01" @default.
• W2987161714 modified "2023-09-30" @default.
• W2987161714 title "<p>MicroRNA-769-5p Promotes The Growth Of Glioma Cells By Targeting Lysine Methyltransferase 2A</p>" @default.
• W2987161714 cites W144423133 @default.
• W2987161714 cites W2002995168 @default.
• W2987161714 cites W2036044314 @default.
• W2987161714 cites W2078510083 @default.
• W2987161714 cites W2117977572 @default.
• W2987161714 cites W2153234291 @default.
• W2987161714 cites W2210138065 @default.
• W2987161714 cites W2345362153 @default.
• W2987161714 cites W2517778619 @default.
• W2987161714 cites W2597632520 @default.
• W2987161714 cites W2626081362 @default.
• W2987161714 cites W2728193951 @default.
• W2987161714 cites W2728934905 @default.
• W2987161714 cites W2737301927 @default.
• W2987161714 cites W2763882129 @default.
• W2987161714 cites W2775401927 @default.
• W2987161714 cites W2786479496 @default.
• W2987161714 cites W2797029723 @default.
• W2987161714 cites W2800596816 @default.
• W2987161714 cites W2802554845 @default.
• W2987161714 cites W2808635653 @default.
• W2987161714 cites W2888430926 @default.
• W2987161714 cites W2889646458 @default.
• W2987161714 cites W2892080287 @default.
• W2987161714 cites W2899543731 @default.
• W2987161714 cites W2903938543 @default.
• W2987161714 cites W2904233876 @default.
• W2987161714 cites W2906980458 @default.
• W2987161714 cites W2918542186 @default.
• W2987161714 cites W2935697369 @default.
• W2987161714 cites W2945873006 @default.
• W2987161714 cites W2948985166 @default.
• W2987161714 cites W2989598674 @default.
• W2987161714 doi "https://doi.org/10.2147/ott.s222836" @default.
• W2987161714 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6842300" @default.
• W2987161714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31807002" @default.
• W2987161714 hasPublicationYear "2019" @default.
• W2987161714 type Work @default.
• W2987161714 sameAs 2987161714 @default.
• W2987161714 citedByCount "8" @default.
• W2987161714 countsByYear W29871617142020 @default.
• W2987161714 countsByYear W29871617142021 @default.
• W2987161714 countsByYear W29871617142022 @default.
• W2987161714 countsByYear W29871617142023 @default.
• W2987161714 crossrefType "journal-article" @default.
• W2987161714 hasAuthorship W2987161714A5020896315 @default.
• W2987161714 hasAuthorship W2987161714A5026786069 @default.
• W2987161714 hasAuthorship W2987161714A5028467032 @default.
• W2987161714 hasAuthorship W2987161714A5029283228 @default.
• W2987161714 hasAuthorship W2987161714A5030212439 @default.
• W2987161714 hasAuthorship W2987161714A5041762312 @default.
• W2987161714 hasAuthorship W2987161714A5075811929 @default.
• W2987161714 hasAuthorship W2987161714A5080256378 @default.
• W2987161714 hasAuthorship W2987161714A5086997094 @default.
• W2987161714 hasAuthorship W2987161714A5088657051 @default.
• W2987161714 hasBestOaLocation W29871617141 @default.
• W2987161714 hasConcept C104317684 @default.
• W2987161714 hasConcept C119056186 @default.
• W2987161714 hasConcept C127561419 @default.
• W2987161714 hasConcept C145059251 @default.
• W2987161714 hasConcept C1491633281 @default.
• W2987161714 hasConcept C173396325 @default.
• W2987161714 hasConcept C185592680 @default.
• W2987161714 hasConcept C190283241 @default.
• W2987161714 hasConcept C2778227246 @default.
• W2987161714 hasConcept C33288867 @default.
• W2987161714 hasConcept C502942594 @default.
• W2987161714 hasConcept C55493867 @default.
• W2987161714 hasConcept C62112901 @default.
• W2987161714 hasConcept C86803240 @default.
• W2987161714 hasConcept C91965660 @default.
• W2987161714 hasConceptScore W2987161714C104317684 @default.
• W2987161714 hasConceptScore W2987161714C119056186 @default.
• W2987161714 hasConceptScore W2987161714C127561419 @default.
• W2987161714 hasConceptScore W2987161714C145059251 @default.
• W2987161714 hasConceptScore W2987161714C1491633281 @default.
• W2987161714 hasConceptScore W2987161714C173396325 @default.
• W2987161714 hasConceptScore W2987161714C185592680 @default.
• W2987161714 hasConceptScore W2987161714C190283241 @default.
• W2987161714 hasConceptScore W2987161714C2778227246 @default.
• W2987161714 hasConceptScore W2987161714C33288867 @default.
• W2987161714 hasConceptScore W2987161714C502942594 @default.
• W2987161714 hasConceptScore W2987161714C55493867 @default.

• next